Literature DB >> 24337065

Inflammation: its role in schizophrenia and the potential anti-inflammatory effects of antipsychotics.

Valeria Mondelli1, Oliver Howes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24337065     DOI： 10.1007/s00213-013-3383-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  15 in total

1.  Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first-episode schizophrenia.

Authors:  Xueqin Song; Xiaoduo Fan; Xue Li; Wei Zhang; Jinsong Gao; Jingping Zhao; Amy Harrington; Douglas Ziedonis; Luxian Lv
Journal:  Psychopharmacology (Berl)       Date:  2013-12-14       Impact factor: 4.530

Review 2.  Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials.

Authors:  Masahiro Nitta; Taishiro Kishimoto; Norbert Müller; Mark Weiser; Michael Davidson; John M Kane; Christoph U Correll
Journal:  Schizophr Bull       Date:  2013-05-29       Impact factor: 9.306

3.  Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.

Authors:  Brian J Miller; Peter Buckley; Wesley Seabolt; Andrew Mellor; Brian Kirkpatrick
Journal:  Biol Psychiatry       Date:  2011-06-08       Impact factor: 13.382

4.  Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine-betahistine combination.

Authors:  Michael Poyurovsky; Camil Fuchs; Artashez Pashinian; Adva Levi; Ronit Weizman; Abraham Weizman
Journal:  Psychopharmacology (Berl)       Date:  2012-12-13       Impact factor: 4.530

5.  Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study.

Authors:  Bart N van Berckel; Matthijs G Bossong; Ronald Boellaard; Reina Kloet; Alie Schuitemaker; Esther Caspers; Gert Luurtsema; Albert D Windhorst; Wiepke Cahn; Adriaan A Lammertsma; René S Kahn
Journal:  Biol Psychiatry       Date:  2008-06-04       Impact factor: 13.382

6.  Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia.

Authors:  Jian-Jun Ou; Yi Xu; Hong-Hui Chen; Xiaoduo Fan; Keming Gao; Juan Wang; Xiao-Feng Guo; Ren-Rong Wu; Jing-Ping Zhao
Journal:  Psychopharmacology (Berl)       Date:  2012-08-28       Impact factor: 4.530

7.  A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.

Authors:  Charles L Raison; Robin E Rutherford; Bobbi J Woolwine; Chen Shuo; Pamela Schettler; Daniel F Drake; Ebrahim Haroon; Andrew H Miller
Journal:  JAMA Psychiatry       Date:  2013-01       Impact factor: 21.596

8.  Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume.

Authors:  Paola Dazzan; Carmine M Pariante; Valeria Mondelli; Annamaria Cattaneo; Martino Belvederi Murri; Marta Di Forti; Rowena Handley; Nilay Hepgul; Ana Miorelli; Serena Navari; Andrew S Papadopoulos; Katherine J Aitchison; Craig Morgan; Robin M Murray
Journal:  J Clin Psychiatry       Date:  2011-05-18       Impact factor: 4.384

9.  A prospective study of impairment in glucose control caused by clozapine without changes in insulin resistance.

Authors:  Oliver D Howes; Ajay Bhatnagar; Fiona P Gaughran; Stephanie A Amiel; Robin M Murray; Lyn S Pilowsky
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112

10.  Haloperidol and olanzapine mediate metabolic abnormalities through different molecular pathways.

Authors:  V Mondelli; C Anacker; A C Vernon; A Cattaneo; S Natesan; M Modo; P Dazzan; S Kapur; C M Pariante
Journal:  Transl Psychiatry       Date:  2013-01-15       Impact factor: 6.222
View more
  17 in total

Review 1.  Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?

Authors:  David Baumeister; Simone Ciufolini; Valeria Mondelli
Journal:  Psychopharmacology (Berl)       Date:  2015-08-14       Impact factor: 4.530

2.  Haloperidol and Risperidone at high concentrations activate an in vitro inflammatory response of RAW 264.7 macrophage cells by induction of apoptosis and modification of cytokine levels.

Authors:  Ivo Emílio da Cruz Jung; Alencar Kolinski Machado; Ivana Beatrice Mânica da Cruz; Fernanda Barbisan; Verônica Farina Azzolin; Thiago Duarte; Marta Maria Medeiros Frescura Duarte; Pedro Antônio Schmidt do Prado-Lima; Guilherme Vargas Bochi; Gustavo Scola; Rafael Noal Moresco
Journal:  Psychopharmacology (Berl)       Date:  2015-09-21       Impact factor: 4.530

3.  Chronic phencyclidine induces inflammatory responses and activates GSK3β in mice.

Authors:  Shenghua Zhu; Hongxing Wang; Ruoyang Shi; Ruiguo Zhang; Junhui Wang; Lynda Kong; Yingxia Sun; Jue He; Jiming Kong; Jun-Feng Wang; Xin-Min Li
Journal:  Neurochem Res       Date:  2014-10-01       Impact factor: 3.996

Review 4.  Translating the MAM model of psychosis to humans.

Authors:  Gemma Modinos; Paul Allen; Anthony A Grace; Philip McGuire
Journal:  Trends Neurosci       Date:  2014-12-30       Impact factor: 13.837

5.  IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia.

Authors:  Emily G Severance; Kristin L Gressitt; Armin Alaedini; Cathrin Rohleder; Frank Enning; J Malte Bumb; Juliane K Müller; Emanuel Schwarz; Robert H Yolken; F Markus Leweke
Journal:  Brain Behav Immun       Date:  2014-09-20       Impact factor: 7.217

6.  Immune influences on the brain: new findings and implications for treatment.

Authors:  Theodora Duka; Neil A Harrison; Oliver D Howes
Journal:  Psychopharmacology (Berl)       Date:  2016-05       Impact factor: 4.530

7.  Brain TSPO imaging and gray matter volume in schizophrenia patients and in people at ultra high risk of psychosis: An [11C]PBR28 study.

Authors:  Sudhakar Selvaraj; Peter S Bloomfield; Bo Cao; Mattia Veronese; Federico Turkheimer; Oliver D Howes
Journal:  Schizophr Res       Date:  2017-10-12       Impact factor: 4.939

Review 8.  Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs-Influence of Smoking Behavior and Inflammation on Pharmacokinetics.

Authors:  Nicole Moschny; Gudrun Hefner; Renate Grohmann; Gabriel Eckermann; Hannah B Maier; Johanna Seifert; Johannes Heck; Flverly Francis; Stefan Bleich; Sermin Toto; Catharina Meissner
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-27

Review 9.  Systematic review and meta-analysis of circulating S100B blood levels in schizophrenia.

Authors:  Katina Aleksovska; Emanuele Leoncini; Stefano Bonassi; Alfredo Cesario; Stefania Boccia; Alessandra Frustaci
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

10.  Assessment of the Human Kynurenine Pathway: Comparisons and Clinical Implications of Ethnic and Gender Differences in Plasma Tryptophan, Kynurenine Metabolites, and Enzyme Expressions at Baseline and After Acute Tryptophan Loading and Depletion.

Authors:  Abdulla A-B Badawy; Donald M Dougherty
Journal:  Int J Tryptophan Res       Date:  2016-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.